Ocular Therapeutix grants inducement equity awards to 15 new hires under 2019 plan
OCUL•Ocular Therapeutix granted inducement equity awards to 15 newly hired non-executive employees, effective Oct. 5, 2026. The awards cover 70,150 stock options priced at $7.25 per share and 22,900 restricted stock units.
1. Award details
The stock options have a 10-year term and vest over four years, with 25% vesting after one year and the remainder vesting monthly over the next three years. The restricted stock units vest in equal annual installments over three years.
